Priority Date: 16.09.11 (US 201161535608P)

RNA ENGINEERED T CELLS FOR THE TREATMENT OF CANCER

  • Application ID: EP12832609
  • Status: GRANT OF PATENT INTENDED

Applicant

Attorney

Employment test 201 - 500 employees
Company dna grunecker kinkeldey stockmair and schwanhausser
operating since 1924
Headquarter in Munich and 2 offices
active in Legal Services

Specialization

This EP application has the IPC class A61, C12, and H01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, IP Asset LLP, Schneiter & Vuille, SR Huebner & Kollegen and 15 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 16.09.2011 - Priority Date (US 201161535608P)
  • 21.03.2013 - Publication A2 (WO2013040557)
  • 23.07.2014 - Publication A2 (EP2756521)

IPC Classification